Molecular Imaging: Page 67

ImaginAb inks deal with pharma developer in China

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAb has signed an exclusive license with DongCheng Pharmaceutical Group to commercialize cancer imaging radiotracers across China.

May 24, 2022

AI software could help cut PET scan times in half

By Will Morton

An artificial intelligence (AI) algorithm can improve image quality in half-count F-18 FDG-PET scans, a finding that paves the way for significant cuts in acquisition time in routine clinical practice, according to French researchers.

May 24, 2022

Shine taps new general manager for therapeutics division

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has named Chris Vessell as general manager of the company's therapeutics division.

May 22, 2022

FAPI-PET shows promise detecting biliary tract cancer

By Will Morton

Fibroblast-activation protein inhibitor (FAPI)-PET imaging proved to be superior to current methods such as FDG-PET for staging patients with biliary tract tumors for surgery in a study published May 17 in Radiology.

May 22, 2022

United Imaging installs total-body PET at Mich. hospital

By AuntMinnie.com staff writers

United Imaging has installed one of its uExplorer total-body PET scanners at Bold Advanced Medical Future Health in Grand Rapids, MI. This is United Imaging's second installation of a uExplorer scanner in the U.S.

May 18, 2022

PET/MRI provides new insights into knee osteoarthritis

By Will Morton

PET/MRI has identified which compartments of the knee may be the best targets for new treatments for early osteoarthritis, according to a study published May 16 in Clinical Radiology.

May 18, 2022

Brigham and Women's gets FDA warning letter on PET tracers

By Will Morton

Brigham and Women's Hospital in Boston has responded to a recent warning letter it received from the U.S. Food and Drug Administration (FDA) regarding "significant violations" at its facility for producing PET radiotracers.

May 17, 2022

Kubtec to acquire Oncovision's GammaPro system

By AuntMinnie.com staff writers

Digital x-ray firm Kubtec has signed a deal to acquire the GammaPro sentinel lymph node probe from Spanish medical technology developer Oncovision.

May 15, 2022

SNMMI updates guidelines on PSMA-PET imaging

By Will Morton

The Society for Nuclear Medicine and Molecular Imaging (SNMMI) is now considering all PSMA-PET radiotracers for detecting prostate cancer -- whether approved or not -- as equivalent, and it will refer to them as a class ("PSMA PET"), according to a recent update of the society's Appropriate Use Criteria.

May 12, 2022

Monrol to supply Telix with Lu-177 for renal cancer trial

By AuntMinnie.com staff writers

Eczacıbaşı-Monrol Nuclear Products will provide lutetium-177 (Lu-177) to Telix Pharmaceuticals Limited for a phase II clinical trial of its Starlite 2 renal cancer therapy medication TLX250.

May 10, 2022

Week in Review: PET/CT guides Pluvicto treatment | Chest wall ultrasound | ISMRM 2022 coverage

By Brian Casey

May 6, 2022

Novartis suspends shipments of Lu-177 ligand therapy agents

By AuntMinnie.com staff writers

Novartis has temporarily suspended supply of its two therapeutic radiopharmaceuticals based on lutetium-177 (Lu-177) ligands due to "quality issues identified in its manufacturing processes," the company said in a May 5 statement.

May 5, 2022

Previous Page

Page 67 of 611

Next Page